| Similar Articles |
|---|
 |
Bio-IT World
February 2006
Kevin Davies |
Solexa Readies 1G Genetic Analyzer Solexa, one of the firms vying to crack the $1,000 genome threshold, has officially launched its first commercial genome sequencing instrument.   |
BusinessWeek
May 9, 2005 |
A Genome Pioneer Looks Forward Dr. Francis Collins discusses the end of the Human Genome Project and says an "outpouring of discoveries" is coming soon. |
Bio-IT World
October 2006
Michael A. Greeley |
What Use Is the $1,000 Genome? Industry is focused on the $1,000 genome -- but investors want to see revenue and profits. The goal of simply reaching the $1,000 genome threshold inherently lacks a business model. What are the applications or products or services that will be unleashed by reaching that milestone? |
Science News
April 24, 2004 |
DNA Day An ivitation to commemorating the completion of the Human Genome Project in 2003 and the description of DNA's structure as a double helix in 1953. |
IEEE Spectrum
February 2010
Mark Anderson |
Genome as Commodity In a few years, millions will have purchased their own genome. The cultural ramifications of a $100 genome are as wide and deep as those of any other recent innovation, including search engines and cellphones. |
Wired
November 17, 2007 |
Genomics Smackdown A debate on whether it's better to know your genetic predisposition to disease or to live in ignorant bliss. |
Bio-IT World
April 2007 |
News Briefs Molecular Medicine's "Best of Show"... Dissolving Assets... Combined Forces... |
Chemistry World
September 14, 2011
David Bradley |
Brewing up Synthetic Yeast Yeast with synthetic genomes could be very useful for medicinal chemists and drug companies. |
The Motley Fool
February 28, 2008
Brian Lawler |
Too Much Hope in Human Genome Shares Human Genome announces its guidance for 2008. Investors, take note. |
Science News
June 10, 2006 |
Science Safari: Medicine in the News This Web site from the University of Pennsylvania School of Medicine serves as a clearinghouse for timely medical information. |
Bio-IT World
October 2005 |
New Products Minimizing Variation, Maximizing Results... Speeding Up with GEArray Express... Sizing Down Sample Storage... Software's New Dimension... High-Precision Mouse Genome CGH Microarray... |
Bio-IT World
August 13, 2003
Michael Greeley |
Two Cents on the '$1,000 Genome' Are venture capitalists still looking for 'the killer app'? Funding the next big idea won't be so easy. Affordable, individualized genome sequencing holds great promise, but making the claims sound too grandiose can be dangerous. |
The Motley Fool
October 26, 2011
Brian Orelli |
Down 20%: Benylsta Not Ramping Fast Enough Sales of Human Genome Sciences' new lupus drug Benylsta continues to grow -- just not fast enough to keep investors interest. |
The Motley Fool
March 17, 2011
Brian Orelli |
Eat or Be Eaten? Perhaps Both. Oft-rumored takeout target Human Genome Sciences goes shopping. |
The Motley Fool
August 30, 2007
Brian Lawler |
Human Genome Steps Forward Human Genome Sciences investors got good news as the drugmaker took a quicker-than-expected step in its journey to get its lead drug, hepatitis C treatment Albuferon, on the path to FDA approval. |
Information Today
January 2, 2014 |
Nature Publishing Group Announces OA Journal Nature Publishing Group agreed to co-publish Human Genome Variation, a peer-reviewed, open access journal, with the Japan Society of Human Genetics. |
Pharmaceutical Executive
October 1, 2011
Jill Wechsler |
Guiding a Revolution in Science Francis Collins led the genomic revolution as director of the International Human Genome Project and director of the National Human Genome Research Institute (NHGRI) at the NIH from 1993 to 2008. |
Bio-IT World
August 18, 2004
Kevin Davies |
Bio IT World President's Award: Francis Collins The director of the National Human Genome Research Institute (NHGRI) spoke of collaboration and computation during his acceptance speech. |
Bio-IT World
October 9, 2002
Kevin Davies |
Cracking the 'Druggable Genome' How many potential drug targets are encoded in the human genome? It is a crucial question for every biopharma business. |
BusinessWeek
June 13, 2005
John Carey |
The NIH's Roadmap for Research Charting the human genome was just the beginning. Now the focus is creating pathways that will lead to practical applications. |
Information Today
July 29, 2014 |
Apple Acquires Book Analytics Company BookLamp.org was the demo site for the Book Genome Project, a technology that digitally analyzes books' contents in order to offer recommendations to users. |
Wired
June 23, 2008 |
Expired-Tired-Wired Trends in desserts, Internet privacy protection, and genomes. |
The Motley Fool
April 14, 2011
Brian Orelli |
Human Genome Sciences Will Be Profitable, Eventually With its first drug on the market -- nearly 20 years after the company was founded -- Human Genome Sciences should start to show meaningful revenue this year. |
Inc.
May 2004
Rod Kurtz |
Back to School for Biotech The challenge of starting a biotech company may become easier, thanks to new master's degrees that are issued jointly by schools of management and graduate science programs. |
The Motley Fool
June 14, 2010
Brian Orelli |
No Approval? No Problem! Investors shrug off Human Genome's news about its hepatitis C drug Zalbin. |
The Motley Fool
September 28, 2006
Jack Uldrich |
Is CuraGen Hiding a Genomic Gem? A majority ownership stake in 454 Life Sciences could pay hefty dividends. |
Chemistry World
October 8, 2009
Lewis Brindley |
IBM Enters Race for $1000 Genome Computer giant IBM is bringing its electronics expertise to biotechnology, and entering the race to map the human genome for less than $1000. |
The Motley Fool
July 22, 2011
Brian Orelli |
It's How You Finish That Matters Human Genome Sciences gained approval of the first drug developed for lupus in half a century, but in its first full quarter on the market Benlysta was uninspiring. |
Bio-IT World
November 12, 2002
Kevin Davies |
DNA for Dummies? The journal Nature Genetics has just published a user's guide to the human genome -- and none too soon. |
The Motley Fool
May 29, 2008
Brian Lawler |
Human Genome's Jam-Packed Pipeline This drugmaker has plentiful candidates heading for phase 3 testing. |
Bio-IT World
February 10, 2003
Kevin Davies |
With a Click of the Mouse What do Eminem and Mus musculus have in common? About 30,000 genes, for a start. The author mulls over the second mammalian genome. |
Bio-IT World
June 15, 2003
Kevin Davies |
The Overly Bold and the Beautiful For many (who really ought to know better), the temptation to fetishize DNA is all but irresistible. |
Bio-IT World
October 2005
Dennis A. Gilbert |
The DNA Sequencing Race: From Sprint to Marathon To create faster, cheaper, and better solutions for DNA analysis, we must remain committed to improving both current and new sequencing technologies. Research that just a short while ago might have been considered too complex, too expensive, or just inconceivable is now well within our grasp. |
Information Today
August 4, 2011 |
Elsevier Introduces Genome Viewer The Genome Viewer is a SciVerse application that displays detailed gene or genomic sequence information on the genes mentioned in an article. |
Bio-IT World
April 2006 |
News Blast PE Proteomics... Structural Genomics... Genome Express... Windber Win... |
Bio-IT World
November 12, 2002
Davies et al. |
John Craig Venter Unvarnished The former Celera CEO talks about that company's politics, the future of sequencing technology, and his own genome. |
The Motley Fool
December 10, 2004
Rich Duprey |
Scientists Play Chicken An international scientific consortium decodes the chicken genome. This information may be of use to companies such as Tyson, Pilgrim's Pride, Cal-Maine or even Buffalo Wild Wings. |
The Motley Fool
December 30, 2011
Brian Orelli |
A Bad Year for the 6,300% Miracle Human Genome Sciences falls from grace. |
Bio-IT World
October 2006
Kevin Davies |
Cracking the Cancer Genome Regardless of which technologies win out, or which centers win the lucrative sequencing contracts, the Cancer Genome Atlas has a sublime medical and scientific importance, underscored by the latest findings from Hopkins. |
Bio-IT World
February 2006
Kevin Davies |
The Cancer Genome Atlas Pilot Launches Researchers from the National Cancer Institute and the National Human Genome Research Institute announced the launch of a three-year, $100 million pilot program for the Human Cancer Genome Project. |
Chemistry World
July 13, 2011
Hayley Birch |
Naked mole-rat genome holds clue to beating cancer The recently published draft sequence of the naked mole-rat genome promises to reveal the secrets of its long and remarkably cancer-free existence, potentially providing new targets for anti-cancer drugs. |
Wired
August 2000
Jennifer Hillner |
Area 22 The inside story of the first fully sequenced chromosome. |
HHMI Bulletin
May 2012
Sarah C. P. Williams |
Opening the Floodgates Researchers are using exome sequencing -- zeroing in on the genes that encode proteins -- to explore the biology of certain diseases. |
Chemistry World
May 22, 2014
Philip Ball |
Is junk DNA all garbage? It would be hard to find a recent scientific study that has excited more controversy than that of the international collaboration Encode. They suggested that up to 80% of our DNA was functional. |
Bio-IT World
September 16, 2004
Kevin Davies |
Computing the Genome Boston University's Charles DeLisi explains his involvement with the human genome project and why he has recently turned his attention to systems biology and an AIDS vaccine. |
Bio-IT World
March 2006
Kevin Davies |
Church Inquiry Gets Personal Harvard Medical School geneticist George Church with his plan for the Personal Genome Project is a likely contender for the X Prize that will be awarded to the group or individual that most helps cross the $1,00 genome threshold. |
